Evonik Oxeno Enhances Production of ELATUR® Plasticizers to Meet Rising Market Demand

Evonik Oxeno Enhances Production of ELATUR® Plasticizers to Meet Rising Market Demand

(IN BRIEF) Evonik Oxeno has announced a significant expansion of its production capabilities for INA-based plasticizers, specifically ELATUR® CH (DINCH) and ELATUR® DINCD, to meet the growing market demand. The expansion will take place at the existing C4 production facilities in Marl, ensuring reliable supply and high quality for European customers. Frank Beißmann, Managing Director of Evonik Oxeno, highlighted this as a crucial step in diversifying their plasticizer portfolio. Additionally, the company remains committed to the rigorous scientific evaluation of its products, including VESTINOL® 9, and emphasizes sustainability by offering biobased and circular raw material options.

(PRESS RELEASE) MARL, 2-Oct-2024 — /EuropaWire/ — Evonik Oxeno has unveiled plans for a substantial increase in production capacities for its INA-based plasticizers, ELATUR® CH (DINCH) and ELATUR® DINCD. This expansion comes in response to the rising demand for these innovative plasticizers, which have quickly become essential standards for Evonik Oxeno’s clientele.

Frank Beißmann, Managing Director of Evonik Oxeno, remarked, “This capacity expansion signifies a significant step forward in the diversification of our plasticizer offerings. We are set to commence work on this expansion within the year to address the growing market needs.”

The enhancements will be seamlessly integrated into Evonik’s existing network of C4 production facilities in Marl. Roland Pietz, Vice President of Oxo Alcohols & Plasticizers at Evonik Oxeno, noted, “With the increased capacity, we will ensure our customers benefit from a reliable supply and superior quality produced in Europe.”

Alongside the ELATUR® line, the VESTINOL® 9 (DINP) plasticizer remains a vital part of Evonik’s portfolio. The company is committed to conducting rigorous scientific evaluations of VESTINOL® 9 and all other plasticizers to maintain high supply security for its customers.

Like all products from Evonik Oxeno, ELATUR® CH and ELATUR® DINCD can be produced using mass-balanced approaches with biobased, biocircular, or circular raw materials, as well as green energy solutions.

For further information, visit c4-chemicals.evonik.com.

About Evonik

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15.3 billion and an operating profit (adjusted EBITDA) of €1.66 billion in 2023. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 32,000 employees work together for a common purpose: We want to improve life today and tomorrow.

About Performance Materials

The forever young classics of the Performance Materials Division stand for products and technologies that are continuously improved. They are the basis for many modern applications, for example in the areas of mobility, nutrition, pharmaceuticals or plastics. The divisions portfolio generated sales of €2.55 billion in 2023 with more than 1,700 employees.

Disclaimer

In so far as forecasts or expectations are expressed in this release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

Media Contact:

Phone +49 201 177-01

SOURCE: Evonik